Skip to content

Adult-onset Generalized Morphea

Adult-onset Generalized Morphea : A Retrospective Multicenter Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04264728
Acronym
MORPHEA
Enrollment
100
Registered
2020-02-11
Start date
2019-12-01
Completion date
2020-04-30
Last updated
2020-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Morphea

Keywords

Morphea, Generalized Morphea, Localized Scleroderma

Brief summary

This study aimed to describe the demographical and clinical characteristics of a retrospective cohort of adult-onset GM and to investigate whether these findings differ between patients with an isomorphic and a symmetric pattern of lesion distribution.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age of onset ≥ 18 years * Patients with generalized morphea as defined by criteria established by Laxer and Zulian (4 or more morpheaform plaques larger than 3 centimeters that show tendency to confluence and involve at least 2 different anatomic sites) * Availability of good-quality clinical photographs * Patient who, after being informed, has not expressed his or her opposition to the re-use of his or her data for the purposes of this research

Exclusion criteria

* Patients with linear morphea who met criteria for generalized morphea * Patient's opposition to participate

Design outcomes

Primary

MeasureTime frame
Retrospective study of generalized morphea in adult patients consulted in dermatology departmentsFiles analyzed retrospectily from January 1st, 2019 to September 30, 2019 will be examined

Countries

France

Contacts

Primary ContactCédric LENORMAND, MD
cedric.lenormand@chru-strasbourg.fr33 3 88 11 66 27
Backup ContactAntoine BRAUD, MD
antoine.braud@chru-strasbourg.fr33 3 88 11 66 27

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026